Literature DB >> 7529791

MHC class I signaling in T cells leads to tyrosine kinase activity and PLC-gamma 1 phosphorylation.

S Skov1, N Odum, M H Claesson.   

Abstract

We have studied the biochemical signal pathway leading to a rise in intracellular free calcium concentration ([Ca2+]i) following cross-linking of MHC class I (MHC-I) molecules on human T leukemic Jurkat cells. Evidence is presented that MHC-I signaling is dependent on tyrosine kinase activity before the observed increase in [Ca2+]i. Thus, tyrosine phosphorylation was detected within 5 s after MHC-I cross-linking, whereas an increase in [Ca2+]i was observed after a lag period of 30 s. Moreover, an inhibitor of tyrosine kinases, herbimycin A, almost completely blocked MHC-I-induced tyrosine phosphorylation and the subsequent calcium response. The early tyrosine kinase activity was found to be dependent on expression of the TCR/CD3 complex and the CD45 molecule on the surface of the T cells. Furthermore, MHC-I cross-linking was shown to tyrosine phosphorylate PLC-gamma 1 (phospholipase C-gamma 1). Collectively, these results indicate that the MHC-I signaling pathway is linked to activation of tyrosine kinase(s) in Jurkat cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Dimerization of major histocompatibility complex class I on the surface of THP-1 cells stimulates the expression of inducible nitric oxide synthase and subsequent nitric oxide release.

Authors:  G Bottley; N Fernández
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

3.  MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease.

Authors:  Bradford M Elmer; Myka L Estes; Stephanie L Barrow; A Kimberley McAllister
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

Review 4.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins.

Authors:  Bryce W Carey; Doo Y Kim; Dora M Kovacs
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

6.  Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.

Authors:  Jing Yang; Yabing Cao; Sungyongl Hong; Haiyan Li; Jianfei Qian; Larry W Kwak; Qing Yi
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis.

Authors:  S Skov; P Klausen; M H Claesson
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

Review 8.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

9.  MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling.

Authors:  Simo Xia; Yijie Tao; Likun Cui; Yizhi Yu; Sheng Xu
Journal:  J Immunol Res       Date:  2019-09-09       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.